Rediscovery of a neuroleptic drug in a new form: clopenthixol
Meyers, C.; Lhoas, J.P.; Huvelle, R.
Schweizerische Rundschau für Medizin Praxis 61(26): 869-871
1972
ISSN/ISBN: 1013-2058 PMID: 4564517 Document Number: 48089
Document emailed within 1 workday
Related Documents
Verdeau-Pailles, J. 1976: Treatment of the neuroleptic syndrome by biperiden hydrochloride under its delayed-action form. a 9-month study on 55 hospitalized patients L'Encephale 2(4): 341-347Sakkas, P.; Davis, J.M.; Janicak, P.G.; Wang, Z.Y. 1991: Drug treatment of the neuroleptic malignant syndrome Psychopharmacology Bulletin 27(3): 381-384
Bourgeois, M. 1972: Priapisms during neuroleptic drug administration (3 cases) La Nouvelle Presse Medicale 1(17): 1161
Van Sweden, B. 1984: REM-latency in neuroleptic drug withdrawal. A case report Acta Psychiatrica Belgica 84(3): 235-239
Berrios, G.E. 1982: Neuroleptic-refractory patients and their drug plasma levels L'Encephale 8(4): 465-485
Lisoprawski, A. 1983: Drug abuse experience and neuroleptic prescriptions at the onset of schizophrenia La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 59(25): 1925-1927
Patel, A.L.; Shaikh, W.A.; Khobragade, A.K.; Soni, H.G.; Joshi, A.S.; Sahastrabuddhe, G.S. 2008: Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome Journal of the Association of Physicians of India 56: 49-50
Uchida, S.; Honda, F.; Otsuka, M.; Satoh, Y.; Mori, J.; Ono, T.; Hitomi, M. 1979: Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug Arzneimittel-Forschung 29(10): 1588-1594
Elie, R.; Gagnon, M.A.; Gauthier, R.; Jéquier, J.C. 1975: Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia L'Union Medicale du Canada 104(6): 909-914
2009: Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents Prescrire international 18(104): 251
Lavie, C.J.; Olmsted, T.R.; Ventura, H.O.; Lepler, B.J. 1986: Neuroleptic malignant syndrome. An underdiagnosed reaction to neuroleptic agents? Postgraduate Medicine 80(3): 171-178
Janssen, P.A.; Niemegeers, C.J.; Schellekens, K.H. 1965: Is it Possible to Predict the Clinical Effects of Neuroleptic Drugs (Major Tranquillizers) from Animal Data?i. "neuroleptic Activity Spectra" for Rats Arzneimittel-Forschung 15: 104-117
Nakazono, Y.; Abe, H.; Murakami, H.; Koyabu, N.; Isaka, Y.; Nemoto, Y.; Murata, S.; Tsutsumi, Y.; Ohtani, H.; Sawada, Y. 2005: Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients International Journal of Clinical Pharmacology and Therapeutics 43(4): 163-171
Drtil, M.; Vinar, O.; Taussigová, D. 1973: Maintenance treatment with long-acting neuroleptic drugs in persons with disturbances of social behavior and drug dependence Activitas Nervosa Superior 15(2): 87
Kabes, J.; Balon, R.; Papezová, H. 1986: Maintenance therapy using clopenthixol decanoate in schizophrenic patients Ceskoslovenska Psychiatrie 82(3-4): 189-194
Tomb, R.R.; Grosshans, E. 2001: The rediscovery of previously described dermatoses Archives of Dermatology 137(6): 715-718
Autran, E.; Rigaud, P.; Barral, D.; Villeval, B. 1992: The rediscovery of the corporal scheme Revue de l'Infirmiere 42(8): 24-29
Roy, C.C.; Myres, A.W.; Ste-Marie, M.T.; Pencharz, P.; Haworth, J. 1978: The rediscovery of breast feeding Canadian Medical Association Journal 119(2): 109-113
Viala, A.; Hou, N.; Durand, A.; Ba, B.; Aaes-Jørgensen, T.; Jørgensen, A. 1983: Determination of cis(Z)-clopenthixol and fluphenazine in whole blood and plasma by high-performance liquid chromatography with an internal standard Journal de Pharmacie de Belgique 38(6): 299-303
Walker, C.A. 1983: A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients Pharmatherapeutica 3(5): 289-293